Page 36 - Boston University Chobanian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>New research from Boston Medical Center and Boston University Chobanian &amp; Avedisian School of Medicine&rsquo;s Center for Regenerative Medicine (CReM) found evidence that a novel stem cell treatment, using mRNA technology encapsulated into nanoparticles (LNP) that was successfully used to produce the COVID-19 vaccines, may boost the natural repair mechanism of the liver to regress the diseased tissue caused by either an acute or chronic liver injury. Published in <em>Cell Stem Cell</em>, researchers identified a specific receptor present on the stem cells which can be recognized and activated by the ligand protein called vascular endothelial growth factor A (VEGFA).</p>

Boston universityUnited statesValerie gouon evansBoston university liver biologist programBoston university chobanian avedisian school of medicineBoston medical centerBoston university chobanianAvedisian schoolRegenerative medicineCell stemAssociate professorMedical center